We award Thomson Reuters an Exemplary Morningstar Capital Allocation Rating, which is based on our assessment of a sound balance sheet, exceptional investment efficacy, and appropriate shareholder ...

Expand Energy's merger-driven scale, robust cash flow, and cost synergies support stable profitability. Read why EXE stock is ...

Anthem Biosciences has launched its much-anticipated ₹3,300 crore initial public offering, which is entirely an Offer for Sale (OFS). The Bengaluru-based CRDMO (Contract Research, Development and ...